Premarket Stock Movements: Moderna, Merck Surge on Cancer Vaccine Trial Results
Shares of pharmaceutical companies Moderna (MRNA) and Merck & Co. (MRK) surged premarket after a late-stage trial showed positive results for their personalized cancer vaccine collaboration. At one point, Moderna's stock jumped 57%, while Merck rose over 6%. However, the timeline for submitting U.S. approval applications remains unclear. Other notable movements included Keysight Technologies (KEYS), which climbed nearly 2% after beating third-quarter earnings and revenue expectations. In contrast, Lowe’s Companies (LOW) fell about 2% as it revised its full-year outlook to the lower end of guidance due to weaker home improvement spending. Target Corporation (TGT) dropped slightly despite a better-than-expected quarterly report boosted by tariff refunds. La-Z-Boy Inc. (LZB) plummeted nearly 17%, citing declining earnings and revenue, while Mercury Systems (MRCY) fell over 9% after missing fourth-quarter estimates.
Tickers: $KEYS $LOW $LZB $MRCY $MRK $MRNA $TGT
Topics: clinical_trials earnings_reports pharmaceuticals retail_performance